The largest psychiatric safety meta-analysis to date found that GLP-1 medications were not associated with increased risk of serious psychiatric adverse events overall ( Pierret et al., JAMA Psychiatry, 2025 ), and a post-hoc analysis of the major semaglutide weight management trials found no differences in depression, suicidal ideation, or suicidal behavior compared to placebo ( Wadden et al., JAMA Internal Medicine, 2024 )

Schedule an appointment if you experience: Sudden or significant decrease in sexual desire that affects your quality of life or relationships New-onset erectile dysfunction or difficulty with arousal Painful intercourse or other physical symptoms during sexual activity Concerning changes in sexual function accompanied by other symptoms such as mood changes, fatigue, or hormonal symptoms New or worsening depression or suicidal thoughts (Zepbound carries a warning for suicidal ideation) Severe, persistent abdominal pain (with or without vomiting), which could indicate pancreatitis or gallbladder disease requiring urgent evaluation Your physician can conduct a thorough assessment to identify potential underlying causes
They assist with allergic responses and can reveal digestive tract inflammation
The most complete formulation, geared towards multi-tissue repair